Which GLP-1 medications have the highest and lowest risk of causing pancreatitis?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Current evidence indicates GLP-1 receptor agonists generally do not significantly increase the risk of pancreatitis, with no specific agent consistently identified as having the highest or lowest risk.

Fields of Study & Subjects

Diabetes Treatment and Management Pancreatitis Pathology and Treatment Pharmacovigilance and Adverse Drug Reactions

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
26 March 2026
Language
EN